Iron(III) Coordinated Polymeric Nanomaterial: A Next-Generation Theranostic Agent for High-Resolution T1-Weighted Magnetic Resonance Imaging and Anticancer Drug Delivery.
Diptendu PatraSaikat MukherjeeIpsita ChakrabortyTapan Kumar DashShantibhusan SenapatiRangeet BhattacharyyaRaja ShunmugamPublished in: ACS biomaterials science & engineering (2018)
Theranostic-based nanomedicine plays a crucial role in the field of cancer therapy. This is due to having the capability to combine both therapy and diagnosis together in a single system. Herein a new class of metal-ligand-based nanocarrier in a norbornene backbone has been designed as a theranostic system. Fe3+-terpyridine complex (Fe-Tpy) has been used here as T1 contrast agent for high-resolution MR imaging, and hydrazone-linked doxorubicin is used for effective pH-responsive delivery. Polyethylene glycol functionalized with a folic acid (peg folate) motif is used to make the entire polymeric system dispersible in water for longer retention and site-specific therapy. All these specialty functional groups are anchored in a single system by using the ring-opening metathesis polymerization (ROMP) technique under the norbornene backbone. Relaxivity study and 1D image experiments have shown the utility of Fe-Tpy complex as an effective T1 contrast agent. In vitro studies are performed to confirm the promising potentiality of the nanocarrier as the efficient nanotheranostic system in prostate cancer.
Keyphrases
- drug delivery
- cancer therapy
- contrast enhanced
- high resolution
- magnetic resonance imaging
- prostate cancer
- photodynamic therapy
- magnetic resonance
- drug release
- fluorescence imaging
- computed tomography
- mass spectrometry
- deep learning
- metal organic framework
- machine learning
- visible light
- high speed
- cell therapy
- smoking cessation